✦ LIBER ✦

A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer

✍ Scribed by M. G. Fakih; A. Groman; J. McMahon; G. Wilding; J. R. Muindi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicentre phase II study using increas

✍ Jacqueline Duffour; Sophie Gourgou; Françoise Desseigne; Charles Debrigode; Laur 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 289 KB

A phase I/II trial of vorinostat in comb

✍ Peter M. Wilson; Anthony El-Khoueiry; Syma Iqbal; William Fazzone; Melissa J. La 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 315 KB

Individual 5-FU dose adaptation in metas

✍ Marc Ychou; Jacqueline Duffour; Andrew Kramar; Charles Debrigode; Sophie Gourgou 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 236 KB

Phase I/II trial of topotecan given as c

✍ G. Hütter; H. Szélenyi; P. M. Deckert; U. Keilholz; E. Thiel 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 191 KB

Phase I–II study of high-dose etoposide

✍ Giuseppe Fraschini; Frankie A. Holmes; Laura Esparza; Richard L. Theriault; Aman 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 162 KB

Hyaluronan-Irinotecan improves progressi

✍ Peter Gibbs; Philip R. Clingan; Vinod Ganju; Andrew H. Strickland; Shirley S. Wo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 459 KB